Skip to main content
Top
Published in: Clinical and Experimental Nephrology 6/2009

01-12-2009 | Original Article

Discrepancy between serum levels of low molecular weight proteins in acute kidney injury model rats with bilateral ureteral obstruction and bilateral nephrectomy

Authors: Hidetoshi Tsuda, Yoshitaka Isaka, Shiro Takahara, Masaru Horio

Published in: Clinical and Experimental Nephrology | Issue 6/2009

Login to get access

Abstract

Background

Serum levels of low molecular weight (LMW) proteins, such as cystatin C and beta-2-microglobulin (MG), are used as GFR markers. Ureteral obstruction is a cause of acute kidney injury (AKI). However, it is unclear whether serum concentrations of LMW proteins are increased in postrenal AKI like in intrinsic AKI. To evaluate this question, the responses of serum levels of cystatin C and beta-2-MG were investigated in rats with bilateral ureteral obstruction (BUO) and bilateral nephrectomy (BNX).

Methods

Sixteen SD rats were divided into sham (sham operated), BUO and BNX groups. Serum levels of creatinine, BUN, cystatin C, beta 2-MG and creatine phosphokinase (CPK) were measured after 24 h of the treatments. Cystatin C and beta 2-MG were measured using rat ELISA kits.

Results

In the sham group, the mean ± SD of creatinine, BUN, cystatin C and beta-2-MG were 0.19 ± 0.01 mg/dl, 22.6 ± 1.9 mg/dl, 1.27 ± 0.18 mg/l and 3.57 ± 0.42 mg/l, respectively. Following BNX, the values significantly rose to 4.79 ± 0.17 mg/dl, 116.9 ± 2.6 mg/dl, 2.59 ± 0.18 mg/l and 9.03 ± 0.52 mg/l compared with sham, respectively. Following BUO, they were 3.99 ± 0.25 mg/dl, 130.3 ± 12.9 mg/dl, 1.94 ± 0.35 mg/l and 4.78 ± 0.24 mg/l, respectively. Increasing amounts of creatinine and BUN in BUO were similar to those in BNX. On the other hand, cystatin C and beta-2 MG in BUO were much lower compared with BNX (P < 0.01 and <0.001, respectively). Fold increases of cystatin C and beta-2-MG in BUO were only 51% and 22% of those in BNX, respectively. There was no significant difference in CPK levels between the BUO and BNX groups.

Conclusion

We showed a discrepancy between serum levels of LMW proteins in AKI model rats with BUO and BNX. The reasons for the discrepancy are discussed.
Literature
1.
go back to reference Klahr S, Harris K, Purkerson ML. Effects of obstruction on renal functions. Pediatr Nephrol. 1988;2:34–42.CrossRefPubMed Klahr S, Harris K, Purkerson ML. Effects of obstruction on renal functions. Pediatr Nephrol. 1988;2:34–42.CrossRefPubMed
2.
go back to reference Li C, Wang W, Kwon TH, Knepper MA, Nielsen S, Frøkiær J. Altered expression of major renal Na transporters in rats with bilateral ureteral obstruction and release of obstruction. Am J Physiol Renal Physiol. 2003;285:F889–901.CrossRefPubMed Li C, Wang W, Kwon TH, Knepper MA, Nielsen S, Frøkiær J. Altered expression of major renal Na transporters in rats with bilateral ureteral obstruction and release of obstruction. Am J Physiol Renal Physiol. 2003;285:F889–901.CrossRefPubMed
3.
go back to reference Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol. 1992;38(Suppl 1):S20–7.PubMed Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol. 1992;38(Suppl 1):S20–7.PubMed
5.
go back to reference Okuda Y, Namba S, Nagata M, Hara K, Morita S. Plasma creatinine and cystatin c ratio is useful for discriminate diagnosis of postrenal renal failure. Rinsho Byori. 2008;56:101–7.PubMed Okuda Y, Namba S, Nagata M, Hara K, Morita S. Plasma creatinine and cystatin c ratio is useful for discriminate diagnosis of postrenal renal failure. Rinsho Byori. 2008;56:101–7.PubMed
6.
go back to reference Bökenkamp A, Ciarimboli G, Dieterich C. Cystatin C in a rat model of end-stage renal failure. Ren Fail. 2001;23:431–8.CrossRefPubMed Bökenkamp A, Ciarimboli G, Dieterich C. Cystatin C in a rat model of end-stage renal failure. Ren Fail. 2001;23:431–8.CrossRefPubMed
7.
go back to reference Walker JB. Creatine: biosynthesis, regulation, and function. Adv Enzymol Relat Areas Mol Biol. 1979;50:177–242.PubMed Walker JB. Creatine: biosynthesis, regulation, and function. Adv Enzymol Relat Areas Mol Biol. 1979;50:177–242.PubMed
8.
go back to reference McGuire DM, Tormanen CD, Segal IS, Van Pilsum JF. The effect of growth hormone and thyroxine on the amount of L-arginine:glycine amidinotransferase in kidneys of hypophysectomized rats. Purification and some properties of rat kidney transamidinase. J Biol Chem. 1980;255:1152–9.PubMed McGuire DM, Tormanen CD, Segal IS, Van Pilsum JF. The effect of growth hormone and thyroxine on the amount of L-arginine:glycine amidinotransferase in kidneys of hypophysectomized rats. Purification and some properties of rat kidney transamidinase. J Biol Chem. 1980;255:1152–9.PubMed
9.
go back to reference Crowne EC, Wallace WH, Shalet SM, Addison GM. Price DA Relationship between urinary and serum growth hormone and pubertal status. Arch Dis Child. 1992;67:91–5.CrossRefPubMedPubMedCentral Crowne EC, Wallace WH, Shalet SM, Addison GM. Price DA Relationship between urinary and serum growth hormone and pubertal status. Arch Dis Child. 1992;67:91–5.CrossRefPubMedPubMedCentral
10.
go back to reference Hope A, Clausen G. Renal blood flow and vasodilatory ability prior to and following release of 24 hours bilateral ureteral obstruction in rats. Acta Physiol Scand. 1984;121:363–7.CrossRefPubMed Hope A, Clausen G. Renal blood flow and vasodilatory ability prior to and following release of 24 hours bilateral ureteral obstruction in rats. Acta Physiol Scand. 1984;121:363–7.CrossRefPubMed
11.
go back to reference Siegel NJ, Feldman RA, Lytton B, Hayslett JP, Kashgarian M. Renal cortical blood flow distribution in obstructive nephropathy in rats. Circ Res. 1977;40:379–84.CrossRefPubMed Siegel NJ, Feldman RA, Lytton B, Hayslett JP, Kashgarian M. Renal cortical blood flow distribution in obstructive nephropathy in rats. Circ Res. 1977;40:379–84.CrossRefPubMed
Metadata
Title
Discrepancy between serum levels of low molecular weight proteins in acute kidney injury model rats with bilateral ureteral obstruction and bilateral nephrectomy
Authors
Hidetoshi Tsuda
Yoshitaka Isaka
Shiro Takahara
Masaru Horio
Publication date
01-12-2009
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 6/2009
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-009-0203-5

Other articles of this Issue 6/2009

Clinical and Experimental Nephrology 6/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.